Skip to main content
. 2009 Dec 21;15(47):5953–5959. doi: 10.3748/wjg.15.5953

Table 6.

Proportion of patients on NSAID therapy that received concomitant therapy with a PPI or misoprostol after the medical visit, according to the number of RFs n (%)

Number of RFs Non-restrictive
Restrictive
Phase I Phase II Phase I Phase II
0 268/347 (77.2) 283/352 (80.4) 782/961 (81.4) 728/891 (81.7)
1 536/660 (81.2) 499/598 (83.4) 471/558 (84.4) 504/573 (87.9)
2 453/517 (87.6) 456/536 (85.1) 151/176 (85.8) 168/213 (78.9)
> 2 175/208 (84.1) 201/236 (85.2) 28/37 (75.7) 39/45 (86.7)